Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
0.696
+0.035 (5.33%)
Mar 12, 2025, 4:00 PM EST - Market closed
Prelude Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 12.47 | 25.29 | 30.61 | 31.83 | 218.31 | Upgrade
|
| Short-Term Investments | 121.14 | 207.64 | 171.12 | 259.41 | - | Upgrade
|
| Cash & Short-Term Investments | 133.61 | 232.94 | 201.73 | 291.23 | 218.31 | Upgrade
|
| Cash Growth | -42.64% | 15.47% | -30.73% | 33.40% | 1056.36% | Upgrade
|
| Prepaid Expenses | 2.28 | 2.65 | 2.65 | 3.88 | 2.5 | Upgrade
|
| Total Current Assets | 135.9 | 235.59 | 204.38 | 295.12 | 220.81 | Upgrade
|
| Property, Plant & Equipment | 35.47 | 37.74 | 6.7 | 5.64 | 2.48 | Upgrade
|
| Other Long-Term Assets | 4.15 | 4.34 | 9.42 | 4.35 | 0.3 | Upgrade
|
| Total Assets | 175.52 | 277.67 | 220.5 | 305.1 | 223.59 | Upgrade
|
| Accounts Payable | 7.73 | 4.58 | 6.78 | 7.84 | 3.92 | Upgrade
|
| Accrued Expenses | 14.44 | 14.82 | 12.57 | 9.53 | 7.04 | Upgrade
|
| Current Portion of Leases | 2.7 | 1.48 | 1.83 | 1.74 | - | Upgrade
|
| Other Current Liabilities | 0.77 | 0.95 | 0.52 | 0.09 | 0.42 | Upgrade
|
| Total Current Liabilities | 25.64 | 21.83 | 21.7 | 19.2 | 11.38 | Upgrade
|
| Long-Term Leases | 15.33 | 15.41 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 3.09 | 3.34 | 3.36 | - | 0.03 | Upgrade
|
| Total Liabilities | 44.06 | 40.58 | 25.06 | 19.2 | 11.41 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 714.98 | 693.25 | 531.68 | 505.72 | 319.61 | Upgrade
|
| Retained Earnings | -583.56 | -456.39 | -334.56 | -219.12 | -107.43 | Upgrade
|
| Comprehensive Income & Other | 0.04 | 0.22 | -1.69 | -0.71 | - | Upgrade
|
| Total Common Equity | 131.46 | 237.09 | 195.44 | 285.9 | 212.18 | Upgrade
|
| Shareholders' Equity | 131.46 | 237.09 | 195.44 | 285.9 | 212.18 | Upgrade
|
| Total Liabilities & Equity | 175.52 | 277.67 | 220.5 | 305.1 | 223.59 | Upgrade
|
| Total Debt | 18.03 | 16.89 | 1.83 | 1.74 | - | Upgrade
|
| Net Cash (Debt) | 115.59 | 216.05 | 199.9 | 289.49 | 218.31 | Upgrade
|
| Net Cash Growth | -46.50% | 8.08% | -30.95% | 32.61% | 1072.38% | Upgrade
|
| Net Cash Per Share | 1.52 | 3.58 | 4.22 | 6.29 | 17.49 | Upgrade
|
| Filing Date Shares Outstanding | 55.15 | 54.89 | 47.71 | 47.02 | 45.37 | Upgrade
|
| Total Common Shares Outstanding | 55.15 | 54.89 | 47.7 | 46.99 | 42.49 | Upgrade
|
| Working Capital | 110.25 | 213.76 | 182.68 | 275.91 | 209.43 | Upgrade
|
| Book Value Per Share | 2.38 | 4.32 | 4.10 | 6.08 | 4.99 | Upgrade
|
| Tangible Book Value | 131.46 | 237.09 | 195.44 | 285.9 | 212.18 | Upgrade
|
| Tangible Book Value Per Share | 2.38 | 4.32 | 4.10 | 6.08 | 4.99 | Upgrade
|
| Machinery | 10.33 | 8.97 | 5.72 | 4.38 | 2.72 | Upgrade
|
| Construction In Progress | - | 0.34 | 1.64 | 0.67 | - | Upgrade
|
| Leasehold Improvements | 1.7 | 1.58 | 0.88 | 0.88 | 0.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.